Login / Signup
Combining EGFR inhibitors with SHP2 or LSD1 inhibitors to overcome multidrug resistance in cancer.
Huiqing Zhang
Xinyu Yang
Yihui Song
Bin Yu
Published in:
Future medicinal chemistry (2022)
Keyphrases
</>
small cell lung cancer
papillary thyroid
epidermal growth factor receptor
tyrosine kinase
squamous cell
squamous cell carcinoma
childhood cancer
young adults